Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

January
24
2020

Restore Your Patients’ Confidence with SRT for Keloid Scars

The Issue with Keloid Scars Keloid scars affect 18 million people, and many of them go through life believing that treatment for their embarrassing and sometimes painful scarring is impossible or even non-existent. Thick, unsightly…

January
22
2020

Sensus Healthcare Announces Sculptura™ Shipment to California-based Medical Center Third Sculptura system sold worldwide

BOCA RATON, Fla, Jan. 22, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, is pleased to announce it…

January
17
2020

What Your Patients Should Know About Childhood Skin Cancer

September is Childhood Cancer Awareness month, a campaign to spotlight the types of cancer that largely affect children, draw attention to survivorship issues and raise funds for research and family support. In the US, more…

January
09
2020

Non-Melanoma Skin Cancer & What You Probably Did Not Know

Non-melanoma skin cancer has reportedly increased “33% since 2012” (Practical Dermatology, September 2019). For these skin cancer-related cases, there was reportedly “3.5 million total procedures in 2018… 3.35 million being for non-melanoma skin cancer” (Practical…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy